Lumonus

About

Lumonus provides an AI-native platform that automates and orchestrates radiation oncology workflows for health systems worldwide.

Mission

Lumonus is a digital oncology company offering an AI-powered platform that streamlines end-to-end radiation oncology workflows, including consultation, prescription, and treatment planning. Its flagship products, Lumonus AI Physician and Lumonus AI Dosimetry, help clinicians deliver care more efficiently by automating routine tasks and improving consistency. The system has already supported more than 280,000 cancer treatment consultations and prescriptions and automatically generated over 75,000 treatment plans for hospitals in the United States, Australia, and Europe. Backed by a leadership team with 100+ years of combined clinical and technical experience, Lumonus partners closely with cancer centers to align product features with real-world needs. Following its recent Series B raise, the company will expand U.S. go-to-market and clinical success teams, enhance its flagship products, and build clinical informatics capabilities that leverage real-world evidence. These initiatives aim to deepen adoption, boost operational performance, and enable more personalized, data-driven oncology care globally.

Quick Facts